Skip to main content

JDRF has now rebranded to Breakthrough T1D.
Our name has changed, our mission has not.

Complications

JDRF-funded researchers develop a genetic test to detect diabetic kidney disease early

Researchers have identified genes that predict the development and progression of diabetic kidney disease, giving us the potential to limit how many people with type 1 experience kidney failure and need invasive treatments such as dialysis.
Breakthrough T1D profile picture
Kate Lawton 16 February 2023

Diabetic kidney disease predictive genetic test researchers

Researchers have identified genes that predict the development and progression of diabetic kidney disease, giving us the potential to limit how many people with type 1 experience kidney failure and need invasive treatments such as dialysis.

The researchers, led by JDRF-funded Professor Sam El-Osta, used genetics data from four countries to develop a predictive test for diabetic kidney disease. Team leader of the human epigenetics group, Professor Sam El-Osta from the Department of Diabetes at Monash University, Australia, said: “Our discoveries will influence how we screen people for diabetic kidney disease and improve risk identification, disease prediction and diagnosis.”

What is diabetic kidney disease?

Diabetic kidney disease (DKD) is also called diabetic nephropathy because kidneys are made up of lots of small units called nephrons, which filter blood to remove waste. Diabetes can cause damage to the small blood vessels in the kidneys, which in turn damages the nephrons. DKD affects almost a third of people with type 1 diabetes, so it’s an important topic for type 1 researchers.

How do we currently test for DKD?

Clinicians currently use blood and urine tests as well as samples of a person’s kidneys to assess for DKD. But these measures are only sensitive enough to detect DKD once there is already quite a lot of damage. Dr Ishant Khurana, who was part of the international research team in this study, said: “The early stages of diabetic kidney disease are typically without symptoms. We have developed a reliable method that improves predictive risk and diagnostic accuracy.”

What did the researchers do?

Before now, genetic risk studies for DKD have only looked at the genes themselves, but Professor El-Osta’s team studied small tags attached to the genes. These tags are called DNA methylation and can turn genes on or off. So, even if a person has certain genes, these tags can switch them off, so the genes stop working.

A huge global sample of people with type 1 diabetes

The international research team looked at the DNA methylation tags of people with type 1 diabetes from Finland, Denmark, Hong Kong, and Thailand. They found common patterns in the genetics of people from all these countries. People with type 1 diabetes who had fewer DNA tags (less DNA methylation) had a higher risk of developing DKD.

Developing a genetic test to detect DKD sooner

Using this pattern shown in the research data, the researchers developed a genetic test that shows who is most likely to develop DKD. Professor El-Osta said: “This type of genetic testing is going to be the new standard for early detection and DKD care. Our new blood-based test can be readily available and used in remote areas with the added advantage of being more stable than methods measuring other biological parameters.”

What does this mean for people with type 1 diabetes?

This exciting breakthrough means that people with type 1 will be able to tell earlier whether they are at high risk of developing DKD. This will give people more time to learn about DKD and take precautions to slow the progression of their kidney damage. The researchers hope this early detection will help limit how many people with type 1 experience kidney failure and need invasive treatments such as dialysis.

Where can I read more about this research?

The full study is detailed in a scientific paper published in a journal called Journal of Clinical Investigation. Read the full research study on the early detection of diabetic kidney disease.

Related news

Read more
Dr Ana Cruz in her lab
Research
8 January 2025

Breakthrough in T1D treatment: Engineered islets produce insulin without immunosuppression

Sana Biotechnology, a US-based biotech company, has released clinical data showing that the first person receiving engineered islets from deceased donors is now producing insulin without the need for immunosuppressive drugs.

Read more
Mum and daughter wearing Breakthrough T1D t-shirts and holding a flag in a park.
News
16 December 2024

Research and policy breakthroughs in 2024

Our highlights from a year full of breakthroughs in type 1 diabetes research and advocacy.

Read more
Researcher with microscope
Research
13 December 2024

Breakthrough T1D funds four new type 1 diabetes research projects in the UK

We’ve awarded four new grants to UK researchers to help improve lives and develop cures for people living with type 1 diabetes.

Read more
A photograph of two women. The woman on the right is a healthcare professional who has a hand on the other woman's arm.
Research
12 November 2024

New policy framework launches to improve sex and gender data in UK research

The framework aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.